Pharmaceutical

Actio gains $66m to advance small molecule therapeutics pipeline

Actio Biosciences has closed a Series B financing round, raising $66m for advancing the genetics-driven small molecule therapeutics pipeline

Jun 21, 2025 - 06:00
Actio gains $66m to advance small molecule therapeutics pipeline
Actio Biosciences has closed a Series B financing round, raising $66m for advancing the genetics-driven small molecule therapeutics pipeline
Read the original article

Tags:

Previous Article

UK and US governments pursue contrasting vaccine strategies

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Stop taking Ozempic before surgery, anesthesiologist group recommends

Stop taking Ozempic before surgery, anesthesiologist gr...

Jun 30, 2023

Empress Therapeutics emerges with $50m to fund small molecule development

Empress Therapeutics emerges with $50m to fund small mo...

Jun 21, 2023

Investment opportunities in atopic dermatitis may drive innovation

Investment opportunities in atopic dermatitis may drive...

Sep 8, 2024